CUAMC
China Universal Asset Management Company Portfolio holdings
AUM
$1.06B
1-Year Return
31.81%
This Quarter Return
+14.98%
1 Year Return
+31.81%
3 Year Return
+205.04%
5 Year Return
–
10 Year Return
–
AUM
$787M
AUM Growth
+$273M
(+53%)
Cap. Flow
+$226M
Cap. Flow
% of AUM
28.71%
Top 10 Holdings %
Top 10 Hldgs %
30.43%
Holding
459
New
34
Increased
332
Reduced
39
Closed
19
Top Buys
| 1 |
Microsoft
MSFT
|
$18.2M |
| 2 |
NVIDIA
NVDA
|
$11.9M |
| 3 |
Netflix
NFLX
|
$9.94M |
| 4 |
Amazon
AMZN
|
$7.89M |
| 5 |
Meta Platforms (Facebook)
META
|
$7.84M |
Top Sells
| 1 |
Vanguard World Funds Extended Duration ETF
EDV
|
$3.64M |
| 2 |
Walmart
WMT
|
$3.08M |
| 3 |
Alibaba
BABA
|
$2.59M |
| 4 |
XYZ
Block, Inc.
XYZ
|
$2.4M |
| 5 |
Intel
INTC
|
$2.07M |
Sector Composition
| 1 | Technology | 37.36% |
| 2 | Healthcare | 29.98% |
| 3 | Consumer Discretionary | 13.6% |
| 4 | Communication Services | 8.97% |
| 5 | Financials | 3.47% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
251
Monster Beverage
MNST
$62B
| $278K | 0.04% |
4,694
+2,623
| +127% | +$155K |
|
252
Day One Biopharmaceuticals
DAWN
$759M
| $278K | 0.04% |
16,817
+6,750
| +67% | +$112K |
|
253
Akero Therapeutics
AKRO
$3.52B
| $273K | 0.03% |
10,800
+4,351
| +67% | +$110K |
|
254
DexCom
DXCM
$31.7B
| $272K | 0.03% |
1,962
+968
| +97% | +$134K |
|
255
Roper Technologies
ROP
$56.7B
| $271K | 0.03% |
483
+270
| +127% | +$151K |
|
256
Constellation Energy
CEG
$96.6B
| $264K | 0.03% |
1,428
+795
| +126% | +$147K |
|
257
Vir Biotechnology
VIR
$714M
| $263K | 0.03% |
25,974
+10,414
| +67% | +$105K |
|
258
Ironwood Pharmaceuticals
IRWD
$179M
| $262K | 0.03% |
30,091
+12,030
| +67% | +$105K |
|
259
Pacira BioSciences
PCRX
$1.2B
| $261K | 0.03% |
8,930
+3,557
| +66% | +$104K |
|
260
Xencor
XNCR
$597M
| $260K | 0.03% |
11,755
+4,714
| +67% | +$104K |
|
261
Levi Strauss
LEVI
$8.92B
| $259K | 0.03% |
12,970
| – | – |
|
262
Prothena Corp
PRTA
$442M
| $257K | 0.03% |
10,360
+4,157
| +67% | +$103K |
|
263
AbCellera Biologics
ABCL
$1.24B
| $255K | 0.03% |
56,306
+22,740
| +68% | +$103K |
|
264
Autodesk
ADSK
$68.1B
| $251K | 0.03% |
965
+540
| +127% | +$141K |
|
265
Ligand Pharmaceuticals
LGND
$3.27B
| $251K | 0.03% |
3,437
+1,425
| +71% | +$104K |
|
266
Copart
CPRT
$48.3B
| $251K | 0.03% |
4,337
+2,427
| +127% | +$141K |
|
267
Scholar Rock
SRRK
$3.12B
| $246K | 0.03% |
13,868
+5,522
| +66% | +$98.1K |
|
|
DCPH
268
DELISTED
Deciphera Pharmaceuticals, Inc. Common Stock
DCPH
| $244K | 0.03% |
15,513
+6,241
| +67% | +$98.2K |
|
269
lululemon athletica
LULU
$24.7B
| $242K | 0.03% |
619
+304
| +97% | +$119K |
|
270
Genmab
GMAB
$16.8B
| $240K | 0.03% |
8,024
+3,179
| +66% | +$95.1K |
|
271
Tarsus Pharmaceuticals
TARS
$2.42B
| $239K | 0.03% |
6,567
+2,735
| +71% | +$99.4K |
|
272
Collegium Pharmaceutical
COLL
$1.24B
| $238K | 0.03% |
6,120
+2,344
| +62% | +$91K |
|
273
MannKind Corp
MNKD
$1.64B
| $235K | 0.03% |
51,947
+20,767
| +67% | +$94.1K |
|
274
Victoria's Secret
VSCO
$2.05B
| $234K | 0.03% |
+12,100
| New | +$234K |
|
275
Mirum Pharmaceuticals
MIRM
$3.73B
| $225K | 0.03% |
8,952
+3,558
| +66% | +$89.4K |
|